However, in patients without pre-existing CVD, contrary to most other primary prevention trials with effect sizes of 25%–30%, 3 the relative risk (RR) reduction was only 6% and did not reach statistical significance (HR: 0.94; 0.77–1.15).
← all excerpts
Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach.
1
—
—